Entyvio (vedolizumab): Uses, Side Effects, Interactions, Pictures, Warnings & Dosing – WebMD

What is Entyvio (vedolizumab), and how does it work?

Entyvio is a monoclonal antibody (a type of biologic medicine). It’s also called an integrin receptor antagonist.
Translation: it blocks a specific “homing signal” that helps certain white blood cells move from the bloodstream into the digestive tract.

Vedolizumab targets an integrin called α4β7, which is involved in directing immune cells toward the gut.
By interrupting that pathway, Entyvio can reduce inflammation in the intestinal lining. Many people describe it as “more gut-selective” than some other immune
medicinesthough it can still affect infection risk and requires serious safety monitoring.

Uses: What conditions does Entyvio treat?

In the U.S., Entyvio is used in adults for:

• Moderately to severely active ulcerative colitis (UC)
• Moderately to severely active Crohn’s disease (CD)

These are inflammatory bowel diseases (IBD) where the immune system stays “on” in the digestive tract. Entyvio is usually considered an
advanced therapy, often used when symptoms are significant, inflammation is documented, or other treatments haven’t been enough.

GI professional societies include vedolizumab among recommended options for moderate-to-severe UC and as a treatment option in Crohn’s disease management,
depending on a person’s history and prior medication exposure.

Before starting Entyvio: a practical safety checklist

Before the first dose, your care team typically reviews a safety planbecause starting a biologic without a plan is like going on a road trip without a map,
snacks, or a charging cable.

Tell your clinician about:

• Current or recent infections (including fevers, chronic cough, or wounds that won’t heal)
• History of recurring severe infections
• Any neurologic symptoms you’ve had (new weakness, vision changes, confusion)
• Liver problems or abnormal liver tests
• All medications you take (prescription, OTC, supplements), especially other immune-suppressing drugs
• Vaccination status (you may be asked to get up to date before starting)
• Pregnancy, plans for pregnancy, or breastfeeding

Vaccines: what’s the big deal?

In general, patients on Entyvio can receive non-live vaccines. Live vaccines may be considered in some situations if the benefits outweigh
risks, but that decision should be made with your clinician. If you’re due for vaccines, it’s often easiest to plan them before starting therapy.

Dosing & administration: the “Week 0, Week 2, Week 6…” roadmap

Entyvio can be given two ways:
intravenous (IV) infusion in a clinic/infusion center and, for many patients, subcutaneous (under-the-skin) injection
using a prefilled syringe or an auto-injector pen.

Standard adult dosing schedule

• Week 0: 300 mg IV infusion over about 30 minutes
• Week 2: 300 mg IV infusion over about 30 minutes
• Week 6 and onward: either continue IV or switch to injections

Option A: Continue IV maintenance

If staying on IV, the typical maintenance plan is 300 mg IV every 8 weeks after the Week 6 infusion. Infusions are administered by a
healthcare professional with monitoring during treatment.

Option B: Switch to subcutaneous maintenance (prefilled syringe or pen)

After the first two IV “starter” doses (Week 0 and Week 2), some patients transition to injections:

• Week 6: 108 mg injected under the skin
• Then: 108 mg every 2 weeks

People already doing well on IV therapy after Week 6 may also switch later; the first injection is typically given
in place of the next scheduled IV infusion, then every 2 weeks after that.

When do you stop if it isn’t working?

If there’s no evidence of benefit by Week 14, clinicians often re-check the planthis may include confirming inflammation, considering
alternative therapies, or adjusting strategy based on your response.

Missed dose basics (especially for injections)

If you miss a scheduled dose, contact your care team for instructions. Many clinics recommend taking the dose as soon as possible and then
re-setting your schedulebut your exact plan depends on timing and your overall clinical picture.

Storage & handling (because biologics are picky roommates)

• Refrigerate unopened product (vials, prefilled syringes, and pens) as directed.
• Prefilled syringes/pens can sometimes be kept at room temperature (in the original package) for a limited time when needed (for example, travel).
• Do not freeze. Protect from light. Don’t shake the pen/syringe like it owes you money.

Always follow the Instructions for Use that comes with your specific product, and check with your pharmacist if anything looks off (cloudiness, particles,
or damage).

Side effects: what’s common vs. what’s “call the clinic now”

Common side effects

Many people tolerate Entyvio well. Still, common effects can happenespecially around the time your immune system is getting the memo that you’ve changed
the rules.

• Cold symptoms / nasopharyngitis (stuffy nose, sore throat)
• Headache
• Joint pain (arthralgia) or back pain
• Nausea
• Fever
• Upper respiratory infections, cough, bronchitis, or flu-like illness
• Fatigue
• Rash or itching
• Sinus symptoms or throat pain
• Pain in arms or legs

Injection-site reactions (subcutaneous dosing)

If you use the pen or prefilled syringe, you may see localized reactions like redness, tenderness, itching, or swelling where the medication was injected.
Rotating sites (thighs/abdomen; upper arm for caregiver injections) can help reduce irritation.

Serious side effects and warnings

Serious side effects are less common, but they’re the reason clinicians ask a million questions and pharmacies put a novel-length insert in your bag.
Contact your healthcare provider right away if you notice signs of:

• Allergic or infusion-related reactions:
  rash, itching, swelling of the face/lips/tongue/throat, wheezing, trouble breathing, dizziness, flushing, or feeling your heart race.
• Serious infections:
  fever, persistent cough, shortness of breath, severe sore throat, painful urination, unusual fatigue, or any infection that feels “bigger than a normal cold.”
• Possible liver injury:
  yellowing of skin/eyes (jaundice), dark urine, right upper belly pain, significant fatigue, or loss of appetite.
• Neurologic symptoms that could suggest PML (rare but important):
  new or worsening weakness on one side, clumsiness, vision changes, confusion, memory issues, or personality changes.

Entyvio’s gut-selective approach means it may have a different safety profile than some systemic immunosuppressants, but
the risk of serious infection still matters, and rare postmarketing events have been reported.

Interactions: medicines, biologics, vaccines, and alcohol

Biologic therapy combinations (the “don’t stack the risk” category)

Entyvio generally shouldn’t be used together with certain other powerful immune therapies unless your specialist has a very specific reason and a careful plan.
In particular, clinicians avoid combining Entyvio with:

• Natalizumab products (due to increased concern for serious infections/PML risk)
• TNF blockers (because combining biologics can increase infection risk)

Vaccines (especially live and oral)

Non-live vaccines are generally okay during therapy. Live vaccines may be considered in select situations if benefits outweigh risks.
Some research in prescribing information notes reduced response to at least one killed oral vaccine scenarioso vaccine timing can matter.
Your clinician can help plan this, especially if you travel or need catch-up immunizations.

Other medications and CYP450 considerations

Vedolizumab isn’t a classic “liver enzyme blocker,” but changes in inflammation can affect how the body processes certain drugs.
If you start or stop Entyvio while taking medications that require close monitoring (for example, narrow therapeutic index drugs),
your clinician may check levels or effects and adjust doses as needed.

Food and alcohol

There aren’t well-established food interactions with Entyvio. Alcohol doesn’t have a known direct interaction, but alcohol can worsen GI symptoms for some people
with IBDand liver safety is part of the bigger picture. If you drink, discuss what’s reasonable for your situation.

“Pictures”: what Entyvio looks like in real life

You might see Entyvio in one of these forms:

• IV infusion vial (clinic use):
  A single-dose glass vial containing a white to off-white “cake” (lyophilized powder) that gets reconstituted and diluted before infusion.
• Prefilled syringe (at-home injection):
  A single-dose syringe with a fixed needle; the medicine in the viewing area is typically clear to slightly yellow and may look mildly opalescent.
• Auto-injector pen (Entyvio Pen):
  A single-dose device with a cap and viewing window, designed to deliver the injection with a button/activation process after training.

If you ever notice cloudiness, floating particles, damage to the device, a broken seal, or an expired product, don’t use itcall the pharmacy or your care team.

Monitoring & follow-up: what your care team may track

Entyvio isn’t a “set it and forget it” medication. Your team may monitor:

• Symptoms (stool frequency, bleeding, abdominal pain, urgency, fatigue)
• Inflammation markers (blood tests, stool tests like fecal calprotectin, depending on practice)
• Endoscopy or imaging (to confirm healing and guide long-term decisions)
• Infection screening (such as TB screening based on your history/risk)
• Liver tests if symptoms or labs suggest a problem

If symptoms flare while on treatment, clinicians may confirm whether inflammation is truly back (versus IBS overlap, infection, diet triggers, medication timing,
or stress effects) before changing the plan.

Pregnancy, breastfeeding, and fertility: what’s known

For pregnancy, available registry and published data have not reliably shown an Entyvio-associated increase in major birth defects or miscarriage, but decisions
about biologics in pregnancy should be individualized. Active IBD itself can increase risks during pregnancy, so many treatment decisions focus on maintaining
disease control.

For breastfeeding, vedolizumab is expected to get into breast milk in small amounts and be poorly absorbed by the infant’s GI tract. Still, the “right” plan
depends on the parent’s health, the baby’s situation, and coordination with obstetrics/pediatrics.

If you’re pregnant, trying to conceive, or breastfeeding, bring it up early so your team can plan timing, vaccinations, and monitoring in a coordinated way.

FAQ: quick, practical questions people ask

How long does Entyvio take to work?

Some people notice improvement within the first several weeks, but others need more time. Clinicians often assess whether there’s meaningful benefit by
around the early induction period and will re-check the plan if there’s no sign of improvement by the Week 14 milestone.

Is Entyvio “chemo”?

No. It’s a biologic antibody therapy used to treat immune-driven inflammation in IBD. It’s given through infusion or injection, which sometimes makes it feel
“big and scary,” but it’s not chemotherapy.

Can I switch from infusions to the pen?

Many patients can, after initial IV doses and clinician approval. Some people prefer the routine of infusion centers; others love the convenience of injections.
The best choice is the one you can stick with safely.

Real-world Entyvio experiences (the human part)

Clinical trials and prescribing info tell you what can happen. Real life tells you what it feels like: calendars, insurance calls, infusion chairs,
and the oddly personal relationship you develop with alcohol wipes.

Infusion-day vibes: “I brought snacks, chargers, and my emotional support hoodie.”

For many people, IV Entyvio becomes a predictable routine. You show up, get vitals checked, and the infusion itself is often about 30 minutesthough the total
visit can take longer with check-in, IV placement, and post-infusion observation. Some patients say the hardest part isn’t the medication; it’s the schedule:
arranging rides, missing work or school, and timing appointments when symptoms are flaring and energy is low.

A surprisingly common “win” is the psychological relief of having a structured plan: the next infusion date is on the calendar, and you’re not guessing what
comes next. People often bring headphones, a book, or a show they’ve been savingbecause if you’re going to sit in a chair anyway, you might as well make it
a mini “do-not-disturb” session.

Switching to injections: convenience vs. confidence

When people transition to the prefilled syringe or pen, the biggest perk is obvious: less time in clinics. The biggest hurdle is also obvious:
learning the technique and feeling confident. Many patients describe a short “training phase” where they’re nervous about doing it right
choosing the injection site, letting the pen warm to room temperature, and remembering to rotate sites.

The first few injections can feel awkward, but confidence typically improves with repetition. Some people prefer the pen because it removes the “I can see the
needle” moment; others prefer the syringe because they feel more control. Neither preference is wrong. If anxiety is high, many clinics encourage patients to
do the first home dose with a nurse educator’s guidance (in person or via telehealth) so you’re not alone with a new device and a thousand questions.

Side effects in the real world: patterns people mention

In day-to-day life, people commonly report mild cold-like symptoms, headaches, fatigue, or achy jointssometimes after early doses, sometimes later, and
sometimes not at all. A real-world theme is that it can be hard to tell what’s a medication side effect versus what’s IBD, stress, poor sleep, anemia, or
just “life happening.” Many patients keep a simple symptom log (not a novel, just a few bullets) around dose times to help their clinician see patterns
without guessing.

Measuring success: it’s more than “Do I feel better today?”

Patients often describe Entyvio success as a slow shift: fewer urgent bathroom trips, less bleeding, more stable appetite, and the ability to make plans
without mapping every public restroom like it’s a survival game. But clinicians also look for objective signslab markers, stool testing, or scope findings
because symptoms don’t always tell the full story.

The underrated challenges: logistics, costs, and patience

Real talk: biologics can involve insurance prior authorizations, specialty pharmacies, shipment timing, and co-pay programs. Many people say the paperwork is
more exhausting than the injection. If that’s you, you’re not being dramaticadministrative burden is real. Patient support programs and clinic coordinators
can help, and it’s worth asking for support instead of silently suffering through phone menus.

The other underrated challenge is patience. Some people respond quickly, while others need weeks to see meaningful changes. It can feel discouraging to be
“doing the big treatment” and still not feel normal immediately. If progress is unclear, the most productive next step is usually not doom-scrollingit’s
partnering with your GI team to confirm inflammation status, rule out infection, and decide whether to stay the course or pivot.

Bottom line: many patients experience Entyvio as a manageable routineeither infusion-based or injection-basedwhile others need a different option due to
side effects, lack of response, or changing life circumstances. The best therapy is the one that’s both medically appropriate and realistically doable for you.